Back to News
investment
Italy’s Angelini Said to Explore Catalyst Pharma Acquisition
Manuel Baigorri, Dinesh Nair, Daniele Lepido
Loading...
1 min read
0 likes
⚡ Quantum Brief
Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.
AI Audio Summary
0:00 / 0:00
Click to play
Quantum News · Media Library
Understand this faster with AI
Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.
Tags
drug-discovery
quantum-investment
Source Information
Source: Bloomberg
Discussion
0 professional contributions
Sign in to join this professional discussion.
Be the first to add a constructive contribution.
